| Dr George Joseph Markowitz, MD | |
|
223 N Van Dien Ave, The Valley Hospital, Dept. Of Emergency Medicine, Ridgewood, NJ 07450-2726 | |
| (201) 447-8023 | |
| (201) 447-3201 |
| Full Name | Dr George Joseph Markowitz |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 223 N Van Dien Ave, Ridgewood, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497713713 | NPI | - | NPPES |
| 1950304 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 25MA03833700 (New Jersey) | Primary |
| Entity Name | Valley Emergency Room Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770532665 PECOS PAC ID: 9335135607 Enrollment ID: O20040422000381 |
News Archive
University of Michigan Medical School physicians and scientists earned more than $366 million in National Institutes of Health research funding in federal fiscal year 2009, according to NIH data. In all, the School's faculty brought in more than $435 million in research funding from all sources in U-M fiscal year 2009.
Cipher Pharmaceuticals Inc. today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. The Phase III safety study is being conducted under a Special Protocol Assessment that was granted by the U.S. Food and Drug Administration (FDA).
Lixte Biotechnology Holdings announced today that the company has received a $244,479.25 grant under the Qualifying Therapeutic Discovery Project.
XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, announced today that Israeli biotech investor Alex Rabinovich, its largest shareholder, increased his stake in the Company through his investment in InterCure, an XTL subsidiary, and recent purchases of XTL stock in the market.
Texas authorities are investigating whether Xerox Corp. played a role in allowing dentists to allegedly overbill the state's Medicaid system by millions of dollars.
› Verified 1 days ago
| Entity Name | Emergency Associates Of Montclair Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598112146 PECOS PAC ID: 0244522241 Enrollment ID: O20160712002716 |
News Archive
University of Michigan Medical School physicians and scientists earned more than $366 million in National Institutes of Health research funding in federal fiscal year 2009, according to NIH data. In all, the School's faculty brought in more than $435 million in research funding from all sources in U-M fiscal year 2009.
Cipher Pharmaceuticals Inc. today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. The Phase III safety study is being conducted under a Special Protocol Assessment that was granted by the U.S. Food and Drug Administration (FDA).
Lixte Biotechnology Holdings announced today that the company has received a $244,479.25 grant under the Qualifying Therapeutic Discovery Project.
XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, announced today that Israeli biotech investor Alex Rabinovich, its largest shareholder, increased his stake in the Company through his investment in InterCure, an XTL subsidiary, and recent purchases of XTL stock in the market.
Texas authorities are investigating whether Xerox Corp. played a role in allowing dentists to allegedly overbill the state's Medicaid system by millions of dollars.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr George Joseph Markowitz, MD 43 Rockburn Pass, West Milford, NJ 07480-3114 Ph: (973) 728-9186 | Dr George Joseph Markowitz, MD 223 N Van Dien Ave, The Valley Hospital, Dept. Of Emergency Medicine, Ridgewood, NJ 07450-2726 Ph: (201) 447-8023 |
News Archive
University of Michigan Medical School physicians and scientists earned more than $366 million in National Institutes of Health research funding in federal fiscal year 2009, according to NIH data. In all, the School's faculty brought in more than $435 million in research funding from all sources in U-M fiscal year 2009.
Cipher Pharmaceuticals Inc. today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. The Phase III safety study is being conducted under a Special Protocol Assessment that was granted by the U.S. Food and Drug Administration (FDA).
Lixte Biotechnology Holdings announced today that the company has received a $244,479.25 grant under the Qualifying Therapeutic Discovery Project.
XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, announced today that Israeli biotech investor Alex Rabinovich, its largest shareholder, increased his stake in the Company through his investment in InterCure, an XTL subsidiary, and recent purchases of XTL stock in the market.
Texas authorities are investigating whether Xerox Corp. played a role in allowing dentists to allegedly overbill the state's Medicaid system by millions of dollars.
› Verified 1 days ago
Joseph Yallowitz, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 223 N Van Dien Avenue, The Valley Hospital, Ridgewood, NJ 07450 Phone: 201-444-2019 Fax: 201-444-3604 | |
Howard Eric Felderman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 223 N Van Dien Ave, Ridgewood, NJ 07450 Phone: 201-447-8738 | |
Edward Amores, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 223 N Van Dien Ave, Ridgewood, NJ 07450 Phone: 201-447-8000 | |
Karen Mary Portale, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 223 N Van Dien Avenue, The Valley Hospital, Ridgewood, NJ 07450 Phone: 201-444-2019 Fax: 201-444-3604 | |
Jennifer L Raman, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 223 N Van Dien Ave, The Valley Hospital - Emergency Department, Ridgewood, NJ 07450 Phone: 201-444-2019 Fax: 201-444-3604 | |
Dr. Joyce Mednick, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 223 N Van Dien Ave, Ridgewood, NJ 07450 Phone: 201-447-8737 |